Shift Health Sponsors Research Canada AGM, Unveils Strategic Plan

13 June 2018, OTTAWA—On June 13, 2018 at the Research Canada Annual General Meeting, Shift Health President Dr. Ryan Wiley, who served as the Chair of Research Canada’s Strategic Planning Task Force, presented Research Canada’s 2020 Strategic Plan—Fulfilling the Promise of Collaborative Advocacy Leadership—alongside Research Canada President and CEO, Ms. Deborah Gordon-El-Bihbety.

“This plan positions Research Canada as a collaborative advocacy leader, working with our members, supporters and partners to advance a vibrant, flourishing health research and innovation sector in Canada,” said Dr. Wiley.

Shift Health sponsored the Parliamentary Health Research Caucus Luncheon on Innovations in Healthy Aging and Dr. Wiley moderated a panel on Meeting the Advocacy Challenge for the Health Innovation Ecosystem.

Featured in the photograph above (left to right): Dr. Wiley, President, Shift Health; Dr. Rafi Hofstein, President and CEO, MaRS Innovation; Mr. Peter Brenders, General Manager, Canada, Sanofi Genzyme; Ms. Cynthia Stewart, Director, R&D Alliances, GE Healthcare Canada; Ms. Pamela Fralick, President, Innovative Medicines Canada; and Mr. Andrew Casey, President and CEO, BIOTECanada